CL2004000544A1 - Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati - Google Patents
Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatiInfo
- Publication number
- CL2004000544A1 CL2004000544A1 CL200400544A CL2004000544A CL2004000544A1 CL 2004000544 A1 CL2004000544 A1 CL 2004000544A1 CL 200400544 A CL200400544 A CL 200400544A CL 2004000544 A CL2004000544 A CL 2004000544A CL 2004000544 A1 CL2004000544 A1 CL 2004000544A1
- Authority
- CL
- Chile
- Prior art keywords
- hypertension
- insulinopati
- algosterone
- prevention
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
USO DE UNA COMBINACION DE UNO O MAS ANTAGONISTAS DE RECEPTORES DE LA ALDOSTERONA Y UNO O MAS INHIBIDORES DE LA EPN, UNA COMBINACION DE UNO O MAS ANTAGONISTAS DE RECEPTORES DE LA ALDOSTERONA, UNO O MAS INHIBIDORES DE LA EPN, Y UNO O MAS INHIBIDORES DE LA ECA, O UNA COMBINACION DE UNO O MAS ANTAGONISTAS DE RECEPTORES DE LA ALDOSTERONA Y UNO O MAS INHIBIDORES DE LA VASOPEPTIDASA PARA EL TRATAMIENTO TERAPEUTICO Y/O PROFILAXIS DE UNA CONDICION DE HIPERTENSION, ENFERMEDAD CARDIOVASCULAR, DISFUNCION RENAL, EDEMA, ENFERMEDAD CEREBROVASCULAR, O CONDICION PATOLOGICA DE INSULINOPATIA EN UN SUJETO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45573803P | 2003-03-18 | 2003-03-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004000544A1 true CL2004000544A1 (es) | 2005-01-28 |
Family
ID=33030050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200400544A CL2004000544A1 (es) | 2003-03-18 | 2004-03-17 | Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040192584A1 (es) |
CL (1) | CL2004000544A1 (es) |
TW (1) | TW200507855A (es) |
WO (1) | WO2004082636A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
WO2006063048A2 (en) | 2004-12-06 | 2006-06-15 | Avigen, Inc. | Ibudilast for treating neuropathic pain and associated syndromes |
US7816347B2 (en) | 2004-12-15 | 2010-10-19 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
US20060205625A1 (en) * | 2005-02-18 | 2006-09-14 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
RU2409366C2 (ru) * | 2005-02-18 | 2011-01-20 | Зольвай Фармасьютиклз Гмбх | Фармацевтические композиции, включающие ингибиторы nep, ингибиторы системы, продуцирующей эндогенный эндотелин, и диуретики |
US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
WO2007051007A2 (en) * | 2005-10-28 | 2007-05-03 | Novartis Ag | Combination of antihypertensives with cholesterol-lowering agent |
US20080181876A1 (en) * | 2007-01-30 | 2008-07-31 | Johnson Kirk W | Methods for treating acute and subchronic pain |
WO2008137012A1 (en) * | 2007-05-03 | 2008-11-13 | Avigen, Inc. | Use of a glial attenuator to prevent amplified pain responses caused by glial priming |
WO2017006254A1 (en) * | 2015-07-08 | 2017-01-12 | Novartis Ag | Drug combination comprising an angiotensin ii receptor antagonist, a neutral endopeptidase inhibitor and a mineralcorticoid receptor antagonist |
WO2017029261A1 (de) * | 2015-08-19 | 2017-02-23 | Bayer Pharma Aktiengesellschaft | Kombinationspräparat umfassend finerenone und einen nep-inhibitor (sacubitril) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
ZA817261B (en) * | 1980-10-23 | 1982-09-29 | Schering Corp | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them |
US4337201A (en) * | 1980-12-04 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl substituted prolines |
US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
NZ202903A (en) * | 1981-12-29 | 1988-01-08 | Hoechst Ag | 1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions |
US4555502A (en) * | 1982-09-30 | 1985-11-26 | Merck & Co., Inc. | Aminoacyl-containing dipeptide derivatives useful as antihypertensives |
FI77669C (fi) * | 1983-04-13 | 1989-04-10 | Ciba Geigy Ag | 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat. |
US5192800A (en) * | 1986-12-11 | 1993-03-09 | Pfizer Inc. | Glutaramide diuretic agents |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
EP0644176B1 (en) * | 1993-09-22 | 1995-11-15 | Pfizer Limited | Hydrogenation |
AU5354196A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist |
DE19750002A1 (de) * | 1997-11-12 | 1999-05-20 | Solvay Pharm Gmbh | Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
2004
- 2004-03-17 CL CL200400544A patent/CL2004000544A1/es unknown
- 2004-03-18 US US10/803,317 patent/US20040192584A1/en not_active Abandoned
- 2004-03-18 TW TW093107307A patent/TW200507855A/zh unknown
- 2004-03-18 WO PCT/US2004/008220 patent/WO2004082636A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
TW200507855A (en) | 2005-03-01 |
WO2004082636A3 (en) | 2005-12-29 |
WO2004082636A2 (en) | 2004-09-30 |
US20040192584A1 (en) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2004000544A1 (es) | Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati | |
ECSP14019136A (es) | Combinaciones farmacéuticas de un antagonista del receptor de angiotensina y un inhibidor de endopeptidasa neutra (nep) | |
CL2004000545A1 (es) | Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul | |
WO2004100871A3 (en) | Combination of an aldosterone receptor antagonist and a renin inhibitor | |
EA200870029A1 (ru) | Способ применения антагонистов il-6 с ингибиторами протеасом | |
AR037065A1 (es) | Una composicion farmaceutica en base a bloqueadores de receptores 5ht3 y 5ht4, inhibidores de la bomba de protones y antagonistas de receptores de h2, util para tratar los desordenes gastrointestinales | |
DE602007006961D1 (de) | Cgrp-rezeptorantagonisten | |
TW200630094A (en) | Bilayer tablet | |
UY28766A1 (es) | Compuestos heteropolicíclicos adicionales y su uso como antagonistas del receptor de glutamato metabotrópico | |
EA200901646A1 (ru) | Ингибиторы рецепторных тирозинкиназ и их применение | |
EA200400879A1 (ru) | Двухслойная фармацевтическая таблетка, содержащая телмисартан и диуретик, и её получение | |
ECSP088131A (es) | Asociación de un agente hipnótico de duración de acción larga y un agente hipnótico de duración de acción corta y su aplicación en terapéutica | |
CL2008002885A1 (es) | Anticuerpo anti-receptor de interleucina-6 (il-6); y composicion farmaceutica que lo comprende | |
DK2065384T3 (da) | Tricyklisk thrombinreceptor-antagonist | |
MXPA06014798A (es) | Antagonistas del receptor de hormona para liberar gonadotropina. | |
WO2000051584A3 (en) | Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists | |
TW200628174A (en) | Bilayer tablet | |
MY145089A (en) | Pharmaceutical composition | |
EA200802381A1 (ru) | Лечение желудочно-кишечных расстройств антагонистами cgrp-пептида | |
HK1096293A1 (en) | Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker | |
DK1313485T3 (da) | Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion | |
CL2021001884A1 (es) | Compuestos heterocíclicos como antagonistas de la adenosina. | |
ECSP099336A (es) | Terapia de combinación en secuencia | |
WO2007131041A3 (en) | The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2 | |
MX2011004284A (es) | Metodo para tratar la hipertension arterial pulmonar. |